The burden of uterine fibroids for african-american women: Results of a national survey

Journal of Women's Health

Volumn 22, Issue 10, 2013, Pages 807-816

  Stewart, Elizabeth A ^a   Nicholson, Wanda K ^b   Bradley, Linda ^c   Borah, Bijan J ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ANEMIA; CONTROLLED STUDY; DISEASE SEVERITY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; EUROPEAN AMERICAN; FAMILY; FEMALE; FEMALE FERTILITY; FRIEND; HEALTH STATUS; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MENSTRUATION DISORDER; PHYSICAL ACTIVITY; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UNITED STATES; UTERUS MYOMA; WORK CAPACITY;

ADULT; AFRICAN AMERICANS; COST OF ILLNESS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SURVEYS; HUMANS; LEIOMYOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84885028039     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2013.4334     Document Type: Review

References (51)

1. Carlson KJ, Nichols DH, Schiff I. Indications for hysterectomy. N Engl J Med. 1993;328:856-860
2. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol. 2003;188:100-107
3. Walker CL, Stewart EA. Uterine fibroids: The elephant in the room. Science. 2005;308:1589-1592
4. Laughlin SK, Stewart EA. Uterine leiomyomas: Individualizing the approach to a heterogeneous condition. Obstet Gynecol. 2011;117:396-403
5. Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997;90:967-973
6. Wise LA, Palmer JR, Stewart EA, Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol. 2005;105: 563-568
7. Huyck KL, Panhuysen CI, Cuenco KT, et al. The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters. Am J Obstet Gynecol. 2008;198:168 e161-169
8. Wechter ME, Stewart EA, Myers ER, Kho RM, Wu JM. Leiomyoma-related hospitalization and surgery: Prevalence and predicted growth based on population trends. Am J Obstet Gynecol. 2011;205:492 e491-492 e495
9. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. J Reprod Med. 1996;41:483-490
10. Al-Hendy A, Salama SA. Ethnic distribution of estrogen receptor-Alpha polymorphism is associated with a higher prevalence of uterine leiomyomas in black Americans. Fertil Steril. 2006;86:686-693
11. Pan Q, Luo X, Chegini N. Genomic and proteomic profiling I: Leiomyomas in African Americans and Caucasians. Reprod Biol Endocrinol. 2007;5:34
12. Marsh EE, Shaw ND, Klingman KM, et al. Estrogen levels are higher across the menstrual cycle in African-American women compared with Caucasian women. J Clin Endocrinol Metab. 2011;96:3199-3206
13. Gliklich RE, Leavy MB, Velentgas P, et al. Identification of future needs in the comparative management of uterine fibroid disease. A report on the Priority-Setting Process, Preliminary Data Analysis, and Research Plan. Agency for Healthcare Research and Quality 2011
14. Zimmermann A, Bernuit D, Gerlinger C, Schaefers M, Geppert K. Prevalence, symptoms and management of uterine fibroids: An international Internet-based survey of 21,746 women. BMC Women's Health. 2012;12:6
15. Taran FA, Brown HL, Stewart EA. Racial diversity in uterine leiomyoma clinical studies. Fertil Steril. 2010;94:1500-1503
16. Mosca L, Mochari-Greenberger H, Dolor RJ, Newby LK, Robb KJ. Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010;3: 120-127
17. Shiyanbola OO, Farris KB. Concerns and beliefs about medicines and inappropriate medications: An Internet-based survey on risk factors for self-reported adverse drug events among older adults. Am J Geriatr Pharmacother. 2010;8: 245-257
18. Larocca NG. Impact of walking impairment in multiple sclerosis: Perspectives of patients and care partners. The Patient. 2011;4:189-201
19. Montes G, Lotyczewski BS, Halterman JS, Hightower AD. School readiness among children with behavior problems at entrance into kindergarten: Results from a US national study. Eur J Pediatr. 2012;171:541-548
20. Correcting Data from Online Surveys for the Effects of Nonrandom Selection and Nonrandom Assignment: Harris Interactive; 2000
21. Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new diseasespecific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol. 2002;99: 290-300
22. Roberts D. Killing the Black Body: Race, Reproduction and the Meaning of Liberty. New York: Random House; 1997
23. Hartmann B. Reproductive Rights and Wrongs. New York: Harper & Row; 1987
24. Settnes A, Jorgensen T. Hysterectomy in a Danish cohort. Prevalence, incidence and socio-demographic characteristics. Acta Obstet Gynecol Scand. 1996;75:274-280
25. Harlow BL, Barbieri RL. Influence of education on risk of hysterectomy before age 45 years. Am J Epidemiol. 1999;150: 843-847
26. Augustus CE. Beliefs and perceptions of African American women who have had hysterectomy. J Transcult Nurs. 2002;13:296-302
27. Groff JY, Mullen PD, Byrd T, Shelton AJ, Lees E, Goode J. Decision making, beliefs, and attitudes toward hysterectomy: A focus group study with medically underserved women in Texas. J Women's Health Gend Based Med. 2000;9 Supplement 2:S39-50
28. Powell LH, Meyer P, Weiss G, et al. Ethnic differences in past hysterectomy for benign conditions. Women's Health Issues. 2005;15:179-186
29. Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG. Hysterectomy rates in the United States, 2003. Obstet Gynecol.2007;110:1091-1095
30. Mauskopf J, Flynn M, Thieda P, Spalding J, Duchane J. The economic impact of uterine fibroids in the United States: A summary of published estimates. J Womens Health (Larchmt). 2005;14:692-703
31. Hartmann KE, Birnbaum H, Ben-Hamadi R, et al. Annual costs associated with diagnosis of uterine leiomyomata. Obstet Gynecol. 2006;108:930-937
32. Lee DW, Ozminkowski RJ, Carls GS, Wang S, Gibson TB, Stewart EA. The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids. Journal of Occupational and Environmental Medicine/American College of Occupational and Environmental Medicine. 2007;49:493-506
33. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012;206:211 e211-219
34. Wise LA, Palmer JR, Harlow BL, et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: A prospective study. Am J Epidemiol. 2004;159:113-123
35. Zhao SZ, Wong JM, Arguelles LM. Hospitalization costs associated with leiomyoma. Clinical Therapeutics. 1999; 21:563-575
36. Flynn M, Jamison M, Datta S, Myers E. Health care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol. 2006;195:955-964
37. Dembek CJ, Pelletier EM, Isaacson KB, Spies JB. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids. J Vasc Interv Radiol. 2007;18:1207-1213
38. Carls GS, Lee DW, Ozminkowski RJ, Wang S, Gibson TB, Stewart E. What are the total costs of surgical treatment for uterine fibroids? Journal of Women's Health. 2008;17:1119-1132
39. Lerner D, Mirza FG, Chang H, Renzulli K, Perch K, Chelmow D. Impaired work performance among women with symptomatic uterine fibroids. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 2008;50:1149-1157
40. Lee DW, Gibson TB, Carls GS, Ozminkowski RJ, Wang S, Stewart EA. Uterine fibroid treatment patterns in a population of insured women. Fertil Steril. 2009;91:566-574
41. Merrill RM. Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit. 2008;14:CR24-31
42. Stewart EA, Shuster LT, Rocca WA. Reassessing hysterectomy. Minn Med. 2012;95:36-39
43. Merrill RM, Layman AB, Oderda G, Asche C. Risk estimates of hysterectomy and selected conditions commonly treated with hysterectomy. Ann Epidemiol. 2008;18:253-260
44. Viswanathan M, Hartmann K, McKoy N, et al. Management of uterine fibroids: An update of the evidence. Evidence Report/Technology Assessment. 2007:1-122
45. Stewart EA. Uterine fibroids and evidence-based medicine-not an oxymoron. N Engl J Med. 2012;366:471-473
46. Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol. 2008;31:73-85
47. van der Kooij SM, Hehenkamp WJK, Volkers NA, Birnie E, Ankum WM, Reekers JA. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology. 2010; 203:105.e101-105.e113
48. Moss JG, Cooper KG, Khaund A, et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG: A International Journal of Obstetrics and Gynaecology. 2011;118:936-944
49. Bouwsma EV, Hesley GK, Woodrum DA, et al. Comparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: Reducing symptoms today and tomorrow (FIRSTT) trial. Fertil Steril. 2011;96:704-710
50. Gross KL, Panhuysen CI, Kleinman MS, et al. Involvement of fumarate hydratase in nonsyndromic uterine leiomyomas: Genetic linkage analysis and FISH studies. Genes Chromosomes Cancer. 2004;41:183-190
51. Baird DD, Hill MC, Schectman JM, Hollis BW. Vitamin D and the risk of uterine fibroids. Epidemiology. 2013;24: 447-453